← All bills

S. 3267ASAP Act

Progress: Introduction / referral onlyLatest action: Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S8278-8279)
119th CongressPolicy area: Health
  • Bill CassidyCosponsorSep 28, 2026
  • John KennedyCosponsorJan 12, 2026
Official CRS summary
Official CRS summary (Introduced in Senate version) · Congress.gov(opens in a new tab)

This bill provides for Medicare coverage of blood tests to screen for the early stages of Alzheimer’s disease or related dementias. Specifically, the bill provides for coverage of genomic sequencing blood or blood product tests, or other equivalent tests, that are approved by the Food and Drug Administration.

Introduced Jan 12, 2026
Latest action Nov 20, 2025Congress.gov(opens in a new tab)GovInfo action history(opens in a new tab)Status checked Nov 17, 2026Record permalink

Stable citation: ikhnae.com/bills/119/s/3267

Report an error in this record →

S. 3267 · Congress 119 · Ikhnae